Bioengineering Laboratories was awarded the illustrious (and highly competitive!) SME Instrument Phase 1 grant, appointed by the European Commission to SMEs with a strong growth potential and the ambition to become world-market leaders. The grant will support BEL in undertaking the DIALYBRID project, aimed at revolutionizing the world of hemodialysis with a novel, hybrid vascular access made of Silkothane®.
